N Agarwal1, M Joshi2. 1. Physical Medicine and Rehabilitation, Sawai Man Singh Medical College and Hospital, Jaipur, India. 2. Department of PMR, SMS Medical College & Associate Hospital Jaipur, Jaipur, India.
Abstract
STUDY DESIGN: Randomized longitudinal comparative study. OBJECTIVES: To compare the efficacy of lamotrigine and amitriptyline in the management of traumatic spinal cord injury (SCI)-induced neuropathic pain (NP). SETTING:Sawai Man Singh Medical College and Hospital, Jaipur, India. METHODS: A total of 147 individuals with NP were randomized for a 3-week trial of either amitriptyline or lamotrigine. Amitriptyline was administered orally at doses of 25, 50 and 100 mg once daily at night time, and lamotrigine was administered orally at doses of 25, 50 and 100 mg twice daily, both for 1 week by means of optional titration. Assessment of NP was done at baseline and thereafter at 1, 2 and 3 weeks using Short-form MC Gill Pain Questionnaire-2 (SFMPQ2) scores. RESULTS: There was a significant difference between the mean values of the SFMPQ2 score at baseline and those at each follow-up for amitriptyline. Similar results were seen in the lamotrigine group. When the differences in mean SFMPQ2 scores at different time frames from baseline were compared with those of the other group, values were found to be nonsignificant as seen on the Mann-Whitney U-test. CONCLUSIONS: These findings support the use of both amitriptyline and lamotrigine in the management of NP after traumatic SCI.
RCT Entities:
STUDY DESIGN: Randomized longitudinal comparative study. OBJECTIVES: To compare the efficacy of lamotrigine and amitriptyline in the management of traumatic spinal cord injury (SCI)-induced neuropathic pain (NP). SETTING: Sawai Man Singh Medical College and Hospital, Jaipur, India. METHODS: A total of 147 individuals with NP were randomized for a 3-week trial of either amitriptyline or lamotrigine. Amitriptyline was administered orally at doses of 25, 50 and 100 mg once daily at night time, and lamotrigine was administered orally at doses of 25, 50 and 100 mg twice daily, both for 1 week by means of optional titration. Assessment of NP was done at baseline and thereafter at 1, 2 and 3 weeks using Short-form MC Gill Pain Questionnaire-2 (SFMPQ2) scores. RESULTS: There was a significant difference between the mean values of the SFMPQ2 score at baseline and those at each follow-up for amitriptyline. Similar results were seen in the lamotrigine group. When the differences in mean SFMPQ2 scores at different time frames from baseline were compared with those of the other group, values were found to be nonsignificant as seen on the Mann-Whitney U-test. CONCLUSIONS: These findings support the use of both amitriptyline and lamotrigine in the management of NP after traumatic SCI.
Authors: T N Bryce; F Biering-Sørensen; N B Finnerup; D D Cardenas; R Defrin; E Ivan; T Lundeberg; C Norrbrink; J S Richards; P Siddall; T Stripling; R-D Treede; S G Waxman; E Widerström-Noga; R P Yezierski; M Dijkers Journal: Spinal Cord Date: 2012-02-07 Impact factor: 2.772
Authors: Troels S Jensen; Ralf Baron; Maija Haanpää; Eija Kalso; John D Loeser; Andrew S C Rice; Rolf-Detlef Treede Journal: Pain Date: 2011-07-18 Impact factor: 6.961
Authors: Diana D Cardenas; Catherine A Warms; Judith A Turner; Helen Marshall; Marvin M Brooke; John D Loeser Journal: Pain Date: 2002-04 Impact factor: 6.961
Authors: Diana H Rintala; Sally Ann Holmes; Daisy Courtade; Richard Neil Fiess; Luz Viviana Tastard; Paul G Loubser Journal: Arch Phys Med Rehabil Date: 2007-12 Impact factor: 3.966
Authors: Darya A Meshalkina; Elana V Kysil; Kristina A Antonova; Konstantin A Demin; Tatiana O Kolesnikova; Sergey L Khatsko; Raul R Gainetdinov; Polina A Alekseeva; Allan V Kalueff Journal: Neurochem Res Date: 2018-05-08 Impact factor: 3.996
Authors: Eldon Loh; Magdalena Mirkowski; Alexandria Roa Agudelo; David J Allison; Brooke Benton; Thomas N Bryce; Sara Guilcher; Tara Jeji; Anna Kras-Dupuis; Denise Kreutzwiser; Oda Lanizi; Gary Lee-Tai-Fuy; James W Middleton; Dwight E Moulin; Colleen O'Connell; Steve Orenczuk; Patrick Potter; Christine Short; Robert Teasell; Andrea Townson; Eva Widerström-Noga; Dalton L Wolfe; Nancy Xia; Swati Mehta Journal: Spinal Cord Date: 2022-02-05 Impact factor: 2.473